435 related articles for article (PubMed ID: 17047668)
1. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task.
Varvel SA; Wise LE; Niyuhire F; Cravatt BF; Lichtman AH
Neuropsychopharmacology; 2007 May; 32(5):1032-41. PubMed ID: 17047668
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid amide hydrolase (FAAH) knockout mice exhibit enhanced acquisition of an aversive, but not of an appetitive, Barnes maze task.
Wise LE; Harloe JP; Lichtman AH
Neurobiol Learn Mem; 2009 Nov; 92(4):597-601. PubMed ID: 19524055
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid amide hydrolase (-/-) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task.
Varvel SA; Cravatt BF; Engram AE; Lichtman AH
J Pharmacol Exp Ther; 2006 Apr; 317(1):251-7. PubMed ID: 16352706
[TBL] [Abstract][Full Text] [Related]
4. Effects of endocannabinoid and endovanilloid systems on aversive memory extinction.
Laricchiuta D; Centonze D; Petrosini L
Behav Brain Res; 2013 Nov; 256():101-7. PubMed ID: 23948212
[TBL] [Abstract][Full Text] [Related]
5. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Moreira FA; Kaiser N; Monory K; Lutz B
Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
[TBL] [Abstract][Full Text] [Related]
6. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
[TBL] [Abstract][Full Text] [Related]
7. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic assessment of THC discriminative stimulus properties in fatty acid amide hydrolase knockout and wildtype mice.
Walentiny DM; Vann RE; Wiley JL
Neuropharmacology; 2015 Jun; 93():237-42. PubMed ID: 25698527
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of endocannabinoid catabolic enzymes elicits anxiolytic-like effects in the marble burying assay.
Kinsey SG; O'Neal ST; Long JZ; Cravatt BF; Lichtman AH
Pharmacol Biochem Behav; 2011 Mar; 98(1):21-7. PubMed ID: 21145341
[TBL] [Abstract][Full Text] [Related]
10. The disruptive effects of the CB1 receptor antagonist rimonabant on extinction learning in mice are task-specific.
Niyuhire F; Varvel SA; Thorpe AJ; Stokes RJ; Wiley JL; Lichtman AH
Psychopharmacology (Berl); 2007 Apr; 191(2):223-31. PubMed ID: 17211653
[TBL] [Abstract][Full Text] [Related]
11. The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice.
Booker L; Kinsey SG; Abdullah RA; Blankman JL; Long JZ; Ezzili C; Boger DL; Cravatt BF; Lichtman AH
Br J Pharmacol; 2012 Apr; 165(8):2485-96. PubMed ID: 21506952
[TBL] [Abstract][Full Text] [Related]
12. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity.
Gunduz-Cinar O; MacPherson KP; Cinar R; Gamble-George J; Sugden K; Williams B; Godlewski G; Ramikie TS; Gorka AX; Alapafuja SO; Nikas SP; Makriyannis A; Poulton R; Patel S; Hariri AR; Caspi A; Moffitt TE; Kunos G; Holmes A
Mol Psychiatry; 2013 Jul; 18(7):813-23. PubMed ID: 22688188
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid-mediated improvement on a test of aversive memory in a mouse model of fragile X syndrome.
Qin M; Zeidler Z; Moulton K; Krych L; Xia Z; Smith CB
Behav Brain Res; 2015 Sep; 291():164-171. PubMed ID: 25979787
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
15. Dual fatty acid amide hydrolase and monoacylglycerol lipase blockade produces THC-like Morris water maze deficits in mice.
Wise LE; Long KA; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH
ACS Chem Neurosci; 2012 May; 3(5):369-78. PubMed ID: 22860205
[TBL] [Abstract][Full Text] [Related]
16. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of elevated anandamide on stress and fear-related behaviors: translational evidence from humans and mice.
Mayo LM; Asratian A; Lindé J; Holm L; Nätt D; Augier G; Stensson N; Vecchiarelli HA; Balsevich G; Aukema RJ; Ghafouri B; Spagnolo PA; Lee FS; Hill MN; Heilig M
Mol Psychiatry; 2020 May; 25(5):993-1005. PubMed ID: 30120421
[TBL] [Abstract][Full Text] [Related]
18. Differential endocannabinoid regulation of extinction in appetitive and aversive Barnes maze tasks.
Harloe JP; Thorpe AJ; Lichtman AH
Learn Mem; 2008 Nov; 15(11):806-9. PubMed ID: 18957525
[TBL] [Abstract][Full Text] [Related]
19. Disruption of CB(1) receptor signaling impairs extinction of spatial memory in mice.
Varvel SA; Anum EA; Lichtman AH
Psychopharmacology (Berl); 2005 Jun; 179(4):863-72. PubMed ID: 15619104
[TBL] [Abstract][Full Text] [Related]
20. Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors.
Wise LE; Shelton CC; Cravatt BF; Martin BR; Lichtman AH
Eur J Pharmacol; 2007 Feb; 557(1):44-8. PubMed ID: 17217945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
